STOCK TITAN
  1. Home
  2. Sec-filings
  3. INCY
  4. [Form 4] INCYTE CORP Insider Trading Activity

Incyte Corp (INCY) EVP sells 47,954 shares after exercising options

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Patrick A. Mayes, EVP & Chief Scientific Officer of Incyte, exercised employee stock options covering 45,767 shares and acquired common stock, then reported sale transactions totaling 47,954 shares of common stock on July 31 and August 3, 2026, pursuant to a Rule 10b5-1 trading plan.

The exercised options included grants with exercise prices of $61.18, $72.27 and $105.43 per share. Footnotes state his reported holdings also include 59,537 additional shares underlying unvested restricted stock units.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Mayes Patrick A
Role EVP & Chief Scientific Officer
Sold 47,954 shs ($5.73M)
Approx. gross sale proceeds $5.73M
Approx. exercise cost $3.59M
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) F5 6,055 $0.00 $0.00
Exercise Common Stock 6,055 $105.43 $638K
Sale Common Stock F1 6,055 $120.43 $729K
Exercise Employee Stock Option (right to buy) F2 2,918 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F3 2,284 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F4 2,709 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 3,148 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F6 2,072 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 9,459 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 2,623 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 2,864 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 1,643 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 3,023 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 2,623 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 1,642 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 2,293 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 85 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F5 326 $0.00 $0.00
Exercise Common Stock 2,918 $61.18 $179K
Exercise Common Stock 2,284 $64.25 $147K
Exercise Common Stock 2,709 $61.76 $167K
Exercise Common Stock 3,148 $68.62 $216K
Exercise Common Stock 2,072 $71.93 $149K
Exercise Common Stock 9,459 $72.27 $684K
Exercise Common Stock 2,623 $74.78 $196K
Exercise Common Stock 2,864 $77.67 $222K
Exercise Common Stock 1,643 $80.50 $132K
Exercise Common Stock 3,023 $83.20 $252K
Exercise Common Stock 2,623 $83.58 $219K
Exercise Common Stock 1,642 $85.01 $140K
Exercise Common Stock 2,293 $90.56 $208K
Exercise Common Stock 85 $106.47 $9K
Exercise Common Stock 326 $105.43 $34K
Sale Common Stock 14,661 $119.46 $1.75M
Sale Common Stock 5,332 $119.42 $637K
Sale Common Stock 2,187 $119.47 $261K
Sale Common Stock 6,171 $119.43 $737K
Sale Common Stock 4,695 $119.39 $561K
Sale Common Stock 2,864 $119.40 $342K
Sale Common Stock 1,643 $119.51 $196K
Sale Common Stock 1,642 $119.38 $196K
Sale Common Stock 85 $122.19 $10K
Sale Common Stock 326 $121.69 $40K
Sale Common Stock 2,293 $119.41 $274K
Holdings After Transaction: Employee Stock Option (right to buy) — 10,764 shares (Direct); Common Stock — 61,441 shares (Direct)
Footnotes (6)
  1. F1. This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.
  2. F2. Options granted on January 18, 2024 and will vest monthly through July 14, 2027
  3. F3. Options granted on July 15, 2024 and will vest monthly through July 15, 2028
  4. F4. Options granted on July 14, 2023 and will vest monthly through July 14, 2027
  5. F5. As of July 31st, 2026, the award is fully vested and exercisable.
  6. F6. Options granted on January 17, 2025 and will vest monthly through July 15, 2028
Shares sold 47,954 shares Aggregate common stock sales reported for Patrick A. Mayes
Options exercised 45,767 shares Total shares underlying employee stock options exercised
Example sale price $119.46 per share Per-share price for a common stock sale on 2026-07-31
Example exercise price $61.18 per share Exercise price for an employee stock option exercised on 2026-07-31
Unvested RSU shares 59,537 shares Shares underlying previously reported restricted stock units that have not vested
Employee Stock Option (right to buy) financial
"Security title reported as Employee Stock Option (right to buy)"
restricted stock units financial
"59,537 shares of common stock issuable pursuant to previously reported restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
fully vested and exercisable financial
"As of July 31st, 2026, the award is fully vested and exercisable."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions did Incyte (INCY) EVP Patrick A. Mayes report?
Patrick A. Mayes reported exercising employee stock options covering 45,767 shares and sale transactions totaling 47,954 shares of Incyte common stock on July 31 and August 3, 2026. These trades were marked as occurring under a Rule 10b5-1 trading plan.

How many Incyte (INCY) shares did Patrick A. Mayes sell and at what prices?
Patrick A. Mayes reported selling 47,954 shares of Incyte common stock. Individual sale prices included amounts such as $119.46 and $120.43 per share, based on multiple sale transactions disclosed for July 31 and August 3, 2026.

What stock options did Patrick A. Mayes exercise in this Incyte (INCY) Form 4?
He exercised employee stock options covering 45,767 shares of Incyte common stock. The exercised grants carried exercise prices including $61.18, $72.27 and $105.43 per share, with certain awards noted as fully vested and exercisable as of July 31, 2026.

Were Patrick A. Mayes’s Incyte (INCY) trades made under a Rule 10b5-1 plan?
Yes. The filing’s Rule 10b5-1 checkbox indicates that Patrick A. Mayes’s reported option exercises and related stock sale transactions were carried out under a Rule 10b5-1 trading plan, which is a pre-arranged trading program for insiders.

What unvested equity awards does Patrick A. Mayes still have at Incyte (INCY)?
A footnote states that his reported holdings include 59,537 shares of common stock issuable pursuant to previously reported restricted stock units that have not yet vested. These RSU-based shares are separate from the options exercised and shares sold in this Form 4.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mayes Patrick A
(Last)(First)(Middle)
1801 AUGUSTINE CUT-OFF
(Street)
WILMINGTON DELAWARE 19803
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Chief Scientific Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/31/2026M2,918A$61.1866,546D
Common Stock07/31/2026M2,284A$64.2568,830D
Common Stock07/31/2026M2,709A$61.7671,539D
Common Stock07/31/2026M3,148A$68.6274,687D
Common Stock07/31/2026M2,072A$71.9376,759D
Common Stock07/31/2026M9,459A$72.2786,218D
Common Stock07/31/2026M2,623A$74.7888,841D
Common Stock07/31/2026M2,864A$77.6791,705D
Common Stock07/31/2026M1,643A$80.593,348D
Common Stock07/31/2026M3,023A$83.296,371D
Common Stock07/31/2026M2,623A$83.5898,994D
Common Stock07/31/2026M1,642A$85.01100,636D
Common Stock07/31/2026M2,293A$90.56102,929D
Common Stock07/31/2026M85A$106.47103,014D
Common Stock07/31/2026M326A$105.43103,340D
Common Stock07/31/2026S14,661D$119.4688,679D
Common Stock07/31/2026S5,332D$119.4283,347D
Common Stock07/31/2026S2,187D$119.4781,160D
Common Stock07/31/2026S6,171D$119.4374,989D
Common Stock07/31/2026S4,695D$119.3970,294D
Common Stock07/31/2026S2,864D$119.467,430D
Common Stock07/31/2026S1,643D$119.5165,787D
Common Stock07/31/2026S1,642D$119.3864,145D
Common Stock07/31/2026S85D$122.1964,060D
Common Stock07/31/2026S326D$121.6963,734D
Common Stock07/31/2026S2,293D$119.4161,441D
Common Stock08/03/2026M6,055A$105.4367,496D
Common Stock08/03/2026S6,055D$120.4361,441(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$61.1807/31/2026M2,918 (2)01/17/2034Common Stock2,918$01,328D
Employee Stock Option (right to buy)$64.2507/31/2026M2,284 (3)07/14/2034Common Stock2,284$02,938D
Employee Stock Option (right to buy)$61.7607/31/2026M2,709 (4)07/13/2033Common Stock2,709$01,233D
Employee Stock Option (right to buy)$68.6207/31/2026M3,148 (5)07/01/2028Common Stock3,148$00D
Employee Stock Option (right to buy)$71.9307/31/2026M2,072 (6)01/16/2035Common Stock2,072$02,665D
Employee Stock Option (right to buy)$72.2707/31/2026M9,459 (5)01/03/2029Common Stock9,459$00D
Employee Stock Option (right to buy)$74.7807/31/2026M2,623 (5)01/18/2032Common Stock2,623$00D
Employee Stock Option (right to buy)$77.6707/31/2026M2,864 (5)07/01/2032Common Stock2,864$0191D
Employee Stock Option (right to buy)$80.507/31/2026M1,643 (5)01/16/2030Common Stock1,643$00D
Employee Stock Option (right to buy)$83.207/31/2026M3,023 (5)01/19/2033Common Stock3,023$0202D
Employee Stock Option (right to buy)$83.5807/31/2026M2,623 (5)07/01/2031Common Stock2,623$00D
Employee Stock Option (right to buy)$85.0107/31/2026M1,642 (5)07/01/2029Common Stock1,642$00D
Employee Stock Option (right to buy)$90.5607/31/2026M2,293 (5)01/14/2031Common Stock2,293$00D
Employee Stock Option (right to buy)$106.4707/31/2026M85 (5)07/01/2030Common Stock85$02,207D
Employee Stock Option (right to buy)$105.4307/31/2026M326 (5)11/06/2027Common Stock326$06,055D
Employee Stock Option (right to buy)$105.4308/03/2026M6,055 (5)11/06/2027Common Stock6,055$00D
Explanation of Responses:
1. This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.
2. Options granted on January 18, 2024 and will vest monthly through July 14, 2027
3. Options granted on July 15, 2024 and will vest monthly through July 15, 2028
4. Options granted on July 14, 2023 and will vest monthly through July 14, 2027
5. As of July 31st, 2026, the award is fully vested and exercisable.
6. Options granted on January 17, 2025 and will vest monthly through July 15, 2028
Remarks:
/s/ Elizabeth Feeney, Attorney-In-Fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR